Compare KRNT & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KRNT | BME |
|---|---|---|
| Founded | 2002 | 2005 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Trusts Except Educational Religious and Charitable |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 595.3M | 536.7M |
| IPO Year | 2015 | N/A |
| Metric | KRNT | BME |
|---|---|---|
| Price | $13.90 | $40.46 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $19.75 | N/A |
| AVG Volume (30 Days) | ★ 467.7K | 34.0K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.26% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.44 |
| Revenue | ★ $210,041,000.00 | N/A |
| Revenue This Year | $3.86 | N/A |
| Revenue Next Year | $2.57 | N/A |
| P/E Ratio | ★ N/A | $28.37 |
| Revenue Growth | ★ 5.17 | N/A |
| 52 Week Low | $11.93 | $35.53 |
| 52 Week High | $34.29 | $43.20 |
| Indicator | KRNT | BME |
|---|---|---|
| Relative Strength Index (RSI) | 54.74 | 57.05 |
| Support Level | $13.70 | $39.81 |
| Resistance Level | $14.63 | $40.67 |
| Average True Range (ATR) | 0.46 | 0.42 |
| MACD | 0.13 | -0.16 |
| Stochastic Oscillator | 63.65 | 38.22 |
Kornit Digital Ltd develops, designs and markets digital printing solutions for the world-wide printed textile industry. The company focuses on its DTG and DTF segments of the printed textile industry. Its solutions include digital printing systems, ink and other consumables, associated software and value-added services that allow for large-scale printing of short runs of complex images and designs directly on finished garments and fabrics. It generates revenue from sales of systems, ink and other consumables and service including software subscriptions The company geographically operates in U.S., EMEA, Asia Pacific and other countries. It derives maximum revenue from U.S.
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.